Your browser doesn't support javascript.
loading
[Premature immune senescence and chronic kidney disease: Update and perspectives]. / Maladie rénale chronique et immunosénescence prématurée : données et perspectives.
Crépin, Thomas; Legendre, Mathieu; Courivaud, Cécile; Vauchy, Charline; Laheurte, Caroline; Rebibou, Jean-Michel; Saas, Philippe; Ducloux, Didier; Bamoulid, Jamal.
Afiliação
  • Crépin T; Inserm, UMR 1098, fédération hospitalo-universitaire, Increase, 3, boulevard Fleming, 25000 Besançon, France; LabEx LipSTIC, faculté de médecine et de pharmacie, université Bourgogne-Franche-Comté, 19, rue Ambroise-Paré, 25000 Besançon, France; 7, boulevard Jeanne-d'arc, 21000 Dijon, France; Service
  • Legendre M; Inserm, UMR 1098, fédération hospitalo-universitaire, Increase, 3, boulevard Fleming, 25000 Besançon, France; LabEx LipSTIC, faculté de médecine et de pharmacie, université Bourgogne-Franche-Comté, 19, rue Ambroise-Paré, 25000 Besançon, France; 7, boulevard Jeanne-d'arc, 21000 Dijon, France.
  • Courivaud C; Inserm, UMR 1098, fédération hospitalo-universitaire, Increase, 3, boulevard Fleming, 25000 Besançon, France; LabEx LipSTIC, faculté de médecine et de pharmacie, université Bourgogne-Franche-Comté, 19, rue Ambroise-Paré, 25000 Besançon, France; 7, boulevard Jeanne-d'arc, 21000 Dijon, France; Service
  • Vauchy C; CIC Biothérapie, Inserm CIC-1431, CHU de Besançon, 3, boulevard Fleming, 25000 Besançon, France.
  • Laheurte C; Inserm, UMR 1098, fédération hospitalo-universitaire, Increase, 3, boulevard Fleming, 25000 Besançon, France; Inserm CIC-1431/UMR 1098, EFS Bourgogne-Franche-Comté, plateforme de biomonitoring, 3, boulevard Fleming, 25000 Besançon, France.
  • Rebibou JM; Inserm, UMR 1098, fédération hospitalo-universitaire, Increase, 3, boulevard Fleming, 25000 Besançon, France; LabEx LipSTIC, faculté de médecine et de pharmacie, université Bourgogne-Franche-Comté, 19, rue Ambroise-Paré, 25000 Besançon, France; 7, boulevard Jeanne-d'arc, 21000 Dijon, France.
  • Saas P; Inserm, UMR 1098, fédération hospitalo-universitaire, Increase, 3, boulevard Fleming, 25000 Besançon, France; Inserm CIC-1431/UMR 1098, EFS Bourgogne-Franche-Comté, plateforme de biomonitoring, 3, boulevard Fleming, 25000 Besançon, France.
  • Ducloux D; Inserm, UMR 1098, fédération hospitalo-universitaire, Increase, 3, boulevard Fleming, 25000 Besançon, France; LabEx LipSTIC, faculté de médecine et de pharmacie, université Bourgogne-Franche-Comté, 19, rue Ambroise-Paré, 25000 Besançon, France; 7, boulevard Jeanne-d'arc, 21000 Dijon, France; Service
  • Bamoulid J; Inserm, UMR 1098, fédération hospitalo-universitaire, Increase, 3, boulevard Fleming, 25000 Besançon, France; LabEx LipSTIC, faculté de médecine et de pharmacie, université Bourgogne-Franche-Comté, 19, rue Ambroise-Paré, 25000 Besançon, France; 7, boulevard Jeanne-d'arc, 21000 Dijon, France; Service
Nephrol Ther ; 16(1): 9-18, 2020 Feb.
Article em Fr | MEDLINE | ID: mdl-31848067
ABSTRACT
Immune senescence is associated with age-related diseases (i.e. infectious disease, cardiovascular diseases and cancers). Chronic kidney disease patients die prematurely when compared with general population, because of a higher occurrence of infections, cardiovascular events and cancer. These diseases are commonly observed in the elderly population and frequently associated with immune senescence. Indeed, chronic kidney disease causes a premature aging of the T lymphocyte compartment, widely related to a decrease in thymic function, a phenomenon that plays a key role in the onset of age-related diseases in chronic kidney disease patients. The degree of immune senescence also influences patients' outcome after renal transplantation, particularly the risk of acute rejection and infections. Partial reversion of pre-transplant immune senescence is observed for some renal transplant patients. In conclusion, to reduce the increasing incidence of morbidity and mortality of chronic kidney disease patients, a better knowledge of uremia-induced immune senescence would help to pave the way to build clinical studies and promote innovative therapeutic approaches. We believe that therapeutic reversion and immune senescence prevention approaches will be part of the management of chronic kidney disease patients in the future.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Senilidade Prematura / Insuficiência Renal Crônica / Imunossenescência Limite: Humans Idioma: Fr Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Senilidade Prematura / Insuficiência Renal Crônica / Imunossenescência Limite: Humans Idioma: Fr Ano de publicação: 2020 Tipo de documento: Article